CVE-2023-38956

Description

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.49%
Third-Party Advisory claroty.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://zkteco.com not applicable
https://claroty.com/team82/disclosure-dashboard/cve-2023-38956 third party advisory

Frequently Asked Questions

What is the severity of CVE-2023-38956?
CVE-2023-38956 has been scored as a high severity vulnerability.
How to fix CVE-2023-38956?
To fix CVE-2023-38956, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-38956 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-38956 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.